Indian scientists resurrect World War-era drug to fight malaria
Now, they are working to make this drug more effective using nanotechnology
Malaria-free India: A vision may be more achievable now
The US’ FDA has approved a drug that can flush out a recurring parasite that causes 34 per cent malaria cases in India
Malaria-helping protein identified
By targeting the protein, pharma companies can develop a new drug to treat the disease and block its transmission
Malaria vaccine: India needs it too, say experts
Countries in Africa registered 94 per cent of all malaria cases and deaths that took place globally in 2019; India saw the largest drop …
Nigeria has Africa’s highest malaria death rate — progress is being made, but it’s not enough
Nigeria’s environment is a favourable one in which mosquitoes – the malaria vector – can thrive
Azerbaijan, Tajikistan reach malaria-free milestone
In Tajikistan and Azerbaijan, the last cases of regional spread of Plasmodium vivax malaria were discovered in 2012 and 2014
As a Malian, the slogan 'zero malaria starts with me' has special meaning
Researchers in Africa are in the early stages of developing a genetically modified mosquito that can only produce male offspring
Anti-malaria drug may be repurposed to treat Zika
A team of Indian researchers identify a viral protein that can be targeted by an already available anti-malarial drug — hydroxychloroquine (HCQ)
Progress against malaria continues to plateau: Report
Africa continues to carry the highest burden: It accounted for 94% of the world’s malaria cases and deaths in the last 20 years
Vaccine hope
While Africa gets its first vaccine to fight malaria, India is still in the early stages of clinical trials
World Malaria Day: How Africa plans to fight the disease
Malawi becomes the first African nation to roll out landmark vaccine, Ghana and Kenya to join the league soon; Uganda adopts a new mass action …
Why do we need to worry about antimicrobial resistance in the time of COVID-19?
As more and more antimicrobials are used to control the virus and the co-infections, this indiscriminate use will further increase AMR
Fatal bacterial infections may stem from COVID-19 therapies, AMR a concern: Study
Researchers have found that SARS-CoV-2 and bacteria in lungs may affect each other’s ability to cause damage and worsen the outcome in a …
Ranbaxy launches new anti-malarial drug
It has an efficacy rate of over 95 per cent, claims company